WO2003093415A3 - Methodes utilisees dans le traitement et la prevention d'une infection par vih - Google Patents

Methodes utilisees dans le traitement et la prevention d'une infection par vih Download PDF

Info

Publication number
WO2003093415A3
WO2003093415A3 PCT/US2003/013163 US0313163W WO03093415A3 WO 2003093415 A3 WO2003093415 A3 WO 2003093415A3 US 0313163 W US0313163 W US 0313163W WO 03093415 A3 WO03093415 A3 WO 03093415A3
Authority
WO
WIPO (PCT)
Prior art keywords
hiv infection
prevention
treatment
methods useful
methods
Prior art date
Application number
PCT/US2003/013163
Other languages
English (en)
Other versions
WO2003093415A2 (fr
Inventor
Jean-Jacques Pin
Serge J E Lebecque
Sem Saeland
Ali Amara
Fernando Arenzana-Seisdedos
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Priority to AU2003225191A priority Critical patent/AU2003225191A1/en
Publication of WO2003093415A2 publication Critical patent/WO2003093415A2/fr
Publication of WO2003093415A3 publication Critical patent/WO2003093415A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2851—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

L'invention concerne une méthode de prévention ou de traitement d'une infection par VIH consistant à administrer à un individu le nécessitant une quantité efficace d'un antagoniste de Langerine. Cette invention a également trait à des méthodes d'identification de composés qui interfèrent avec l'infectiosité du VIH et de composés identifiés par ces méthodes.
PCT/US2003/013163 2002-05-02 2003-04-30 Methodes utilisees dans le traitement et la prevention d'une infection par vih WO2003093415A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003225191A AU2003225191A1 (en) 2002-05-02 2003-04-30 Methods useful in treatment and prevention of hiv infection

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37745902P 2002-05-02 2002-05-02
US60/377,459 2002-05-02

Publications (2)

Publication Number Publication Date
WO2003093415A2 WO2003093415A2 (fr) 2003-11-13
WO2003093415A3 true WO2003093415A3 (fr) 2004-02-26

Family

ID=29401501

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/013163 WO2003093415A2 (fr) 2002-05-02 2003-04-30 Methodes utilisees dans le traitement et la prevention d'une infection par vih

Country Status (2)

Country Link
AU (1) AU2003225191A1 (fr)
WO (1) WO2003093415A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200371110A1 (en) * 2018-01-12 2020-11-26 The Wistar Institute Of Anatomy And Biology Methods for identifying and treating hiv persistence

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000018803A2 (fr) * 1998-09-25 2000-04-06 Schering Corporation Anticorps lies a un antigene mammalien de la cellule de langerhans et leurs utilisations

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000018803A2 (fr) * 1998-09-25 2000-04-06 Schering Corporation Anticorps lies a un antigene mammalien de la cellule de langerhans et leurs utilisations

Also Published As

Publication number Publication date
AU2003225191A8 (en) 2003-11-17
AU2003225191A1 (en) 2003-11-17
WO2003093415A2 (fr) 2003-11-13

Similar Documents

Publication Publication Date Title
TW200730537A (en) Methods and compositions for treating hepatitis C virus
WO2000040235A3 (fr) Traitement de l'asthme a l'aide d'inhibiteurs de mek
HK1050999A1 (en) Methods for treating hepatitis delta virus infection with beta-l-2'deoxy-nucleosides.
WO1999052515A3 (fr) Utilisation de liaisons organophosphorees dans le traitement et la prevention d'infections
EP2361913A8 (fr) Agents anti-infectieux
WO2002096363A3 (fr) Methode de traitement de maladies fibreuses ou d'autres indications
WO2002053101A3 (fr) Procede de traitement de troubles fibrogenes et autres symptomes de type ivc
EP1627635A3 (fr) Composés de benzothiazolium utilisés dans des méthodes pour l'inhibition de la production de NO et du TNF alpha et pour le traitement des infections à coronavirus
WO2005044194A3 (fr) Traitement ou prevention de la neoplasie a l'aide d'un inhibiteur de la proteine hsp90
WO2003092606A3 (fr) Inhibiteurs de cholinesterase pour prevenir les blessures causees par des produits chimiques
DE60327557D1 (de) Verwendung von spongosin (2-methoxyadenosin) zur behandlung von schmerzen, insbesondere hyperalgesie
WO2004043456A8 (fr) Inhibiteurs d'absorption du cholesterol pour le traitement de la demyelination
WO2001041754A8 (fr) Inhibiteurs d'agregation plaquettaire induite par le collagene
WO2005082375A3 (fr) Methodes permettant de traiter la cystite interstitielle et composes et compositions connexes
WO2003015708A3 (fr) Traitement de l'infection par le vih et composition a cet effet
ZA991029B (en) Composition and methods for treatment of hiv infections.
WO2003093415A3 (fr) Methodes utilisees dans le traitement et la prevention d'une infection par vih
ATE493408T1 (de) Antiinfektiöse mittel
WO2001010454A3 (fr) Composition et procedes de traitement d'infection par le vih
AU2003254129A1 (en) Method and composition for treating and preventing hepatitis b infection and symptoms thereof
WO2005053613A3 (fr) Combinaisons de traitement d'infections fongiques
WO2004064784A3 (fr) Preparation et methode de prevention ou de traitement d'une infection virale
WO2006085141A3 (fr) Compositions et methodes pour le traitement ou la prevention d'une infection provoquee par hepadnaviridae
WO2002005796A3 (fr) Methode de traitement de l'infection
WO2004033665A3 (fr) Cocktail de plasma heterologue utilise dans le traitement du vih

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CZ DE DK DM DZ EC EE ES FI GB GD GE HR HU ID IL IN IS JP KG KR KZ LC LK LR LT LU LV MA MD MG MK MN MX MZ NI NO NZ PH PL PT RO RU SC SE SG SK SL TJ TM TN TR TT TZ UA UZ VC VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP